Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
โ
of holders' portfolios
13F filers
0
institutions
Market cap
$46.2M
9M shares
52-week range
$4.75 โ $45.33
0% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
www.sanuwave.comNo one on the platform currently holds SNWV.
No tracked institution reports a position in SNWV as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-10-18 | 1-for-375reverse |
No one on the platform has traded SNWV yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$SNWV 2025 net income: $11.8M, vs. a $33.1M loss in 2024.๐
View on StockTwits โhttps://www.marketbeat.com/earnings/reports/2026-8-6-sanuwave-health-inc-stock-1/ $SNWV Sanuwave Health Earnings Transcript
View on StockTwits โ$SNWV Q2 '26 Earnings Results & Recap โข Reported GAAP EPS of -$0.08 down -233.33% YoY โข Reported revenue of $9.74M down -3.13% YoY
View on StockTwits โ$SNWV fresh alert breaking out ๐๐๐
View on StockTwits โ$SNWV How much will earnings suffer if reimbursable rate drops to 100 dollars?
View on StockTwits โ$SNWV no takeout target with this reimbursement rate. Actually looks very expensive.
View on StockTwits โ$SNWV At this price is this a takeout target for a bigger metric company?
View on StockTwits โ$SNWV this thing is toast with the new cms reimbursment rate
View on StockTwits โ$SNWV bought here at $7.25. Looking for $8.50-$10 sooner rather than later. This panic selling is overdone. The management's handling of the intravascular portfolio was a very smart move that unlocked massive value for the company. This allowed them to raise capital without diluting equity share holders! Thank you...you're welcome.
View on StockTwits โRecent $TICKER stream from stocktwits.com โ refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $51M | โ | $-0.08 | $-0.08โ$-0.08 | โ | 1 |
| 2027 | $65M | +25.6% | $0.37 | $0.37โ$0.37 | 12.9ร | 1 |
| 2028 | $2M | -97.5% | $-18.75 | $-18.75โ$-18.75 | โ | 1 |
| 2029 | $5M | +228.8% | $-18.75 | $-18.75โ$-18.75 | โ | 1 |
Forward consensus ยท growth is YoY vs the prior fiscal-year estimate ยท Fwd P/E at the current price ยท source: Financial Modeling Prep
Beat consensus in 2 of the last 5 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $-0.03 | $-0.08 | -166.7% |
| 2026-05-12 | $-0.14 | $-0.17 | -21.4% |
| 2026-03-26 | $0.17 | $0.03 | -82.4% |
| 2025-11-07 | $0.32 | $0.46 | +43.8% |
| 2025-08-08 | $-0.09 | $0.01 | +111.1% |
| $157M |
| โ |
| MASS908 Devices Inc. | $10.11 | +0.90% | $415M | โ |
| NNOXNano-X Imaging Ltd. | $0.98 | -3.43% | $69M | โ |
Source: Financial Modeling Prep ยท peers by sector/industry